Filip Małgorzata, Papla Iwona, Nowak Ewa, Przegaliński Edmund
Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.
Pol J Pharmacol. 2003 Nov-Dec;55(6):1125-30.
In the present study, we attempted to determine the effects of an atypical antipsychotic drug clozapine on the locomotor activation as well as sensitization to cocaine in male Wistar rats. When given acutely to rats, cocaine (10 mg/kg, ip) increased 4-fold the animals' locomotor activity. Repeated administration (1-5 days) of cocaine (10 mg/kg, ip) to rats significantly enhanced on day 10 the locomotor activation induced by its challenge dose given after 5-day withdrawal (sensitization). When given in combination with acute cocaine, clozapine (10 mg/kg, but not 2.5-5 mg/kg) attenuated the locomotor effects of the psychostimulant. In animals pretreated with clozapine (5-10 mg/kg, but not 2.5 mg/kg) before each of the 5 daily cocaine injections, a significant dose-dependent reduction of the locomotor response of animals to the challenge dose of cocaine (10 mg/kg) was observed on day 10. A decrease in that response was also found in animals treated repeatedly with cocaine (days 1-5) and challenged with the psychostimulant combined with clozapine (10 mg/kg, but not 2.5-5 mg/kg) on day 10. The obtained results indicate the ability of clozapine to reduce both acute and sensitizing locomotor responses to cocaine. These findings seem to be in line with recent clinical reports showing that clozapine may be useful in the treatment of cocaine abuse, even in schizophrenic patients.
在本研究中,我们试图确定非典型抗精神病药物氯氮平对雄性Wistar大鼠的运动激活以及对可卡因的敏感性的影响。当急性给予大鼠可卡因(10mg/kg,腹腔注射)时,动物的运动活性增加了4倍。对大鼠重复给药(1 - 5天)可卡因(10mg/kg,腹腔注射),在第10天显著增强了在停药5天后给予其激发剂量所诱导的运动激活(敏化)。当与急性可卡因联合给药时,氯氮平(10mg/kg,但不是2.5 - 5mg/kg)减弱了精神兴奋剂的运动效应。在每天5次可卡因注射前用氯氮平(5 - 10mg/kg,但不是2.5mg/kg)预处理的动物中,在第10天观察到动物对可卡因激发剂量(10mg/kg)的运动反应有显著的剂量依赖性降低。在用可卡因重复处理(第1 - 5天)并在第10天用与氯氮平(10mg/kg,但不是2.5 - 5mg/kg)联合的精神兴奋剂激发的动物中也发现该反应降低。所得结果表明氯氮平具有降低对可卡因的急性和敏化运动反应的能力。这些发现似乎与最近的临床报告一致,表明氯氮平可能对治疗可卡因滥用有用,即使在精神分裂症患者中也是如此。